Comprehensive cancer profiling

After three years of following 240 cancer patients, Roche and Swiss university researchers have reported on their toponomic findings.  “The scope of testing includes the cancer cells’ DNA, RNA and proteins. Single-cell level data provides the researchers an understanding of each tumour’s cellular diversity, which includes not only cancer cells, but also immune cells. . . .  Part of the analysis also includes functional tests, in which biopsies of the tumour are treated with drugs in the laboratory to see if the drugs work. Information from medical imaging and other patient data is also taken into account.”   MORE

Image Credit:  Roche